Female adolescents are at a high risk for human papillomavirus infection and are likely to derive significant benefits from vaccination against this virus. However, administering human papillomavirus vaccines to this age group will require providers to be familiar with several issues unique to the adolescent population.
- Human papillomavirus
ASJC Scopus subject areas
- Obstetrics and Gynecology
TY - JOUR
T1 - Human papillomavirus vaccine and adolescents
AU - Dempsey, Amanda F.
AU - Zimet, Gregory
PY - 2008/10
Y1 - 2008/10
N2 - Lippincott Williams & Wilkins.
AB - Lippincott Williams & Wilkins.
KW - Adolescents
KW - Human papillomavirus
KW - Vaccine
UR - http://www.scopus.com/inward/record.url?scp=55349120159&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55349120159&partnerID=8YFLogxK
U2 - 10.1097/GCO.0b013e3283086719
DO - 10.1097/GCO.0b013e3283086719
M3 - Article
C2 - 18797267
AN - SCOPUS:55349120159
VL - 20
SP - 447
EP - 454
JO - Current Opinion in Obstetrics and Gynecology
JF - Current Opinion in Obstetrics and Gynecology
SN - 1040-872X
IS - 5